While monocytosis (increase in total monocyte count) is commonly observed in depression, it generally reflects an increase in a less classical, more pro-inflammatory monocyte phenotype as opposed to CD16–CD14+ cells (Foley et al., 2023; Daray et al., 2024). Here, CD14 is linked to depressive symptom measurement.